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ÖZET
AMAÇ: Larinks kanseri gelişiminde son yıllarda Human Papillomavirüs (HPV) enfeksiyonları üzerinde 
durulmaktadır. Bu çalışmada larinks Skuamöz hücreli karsinom (SHK)'larında HPV varlığının 
immünohistokimyasal ve Polimeraz zincir reaksiyonu (PZR) dizisi hibrizasyon yöntemiyle araştırılması, ayrıca 
p53, Ki-67 ekspresyonunun HPV varlığı ve klinikopatolojik parametrelerle ilişkisinin ortaya konması 
amaçlanmıştır.
GEREÇ ve YÖNTEM: Larinks SHK nedeniyle opere edilen 47 olgu retrospektif olarak çalışmaya alındı. 
Parafinli bloklardan hazırlanan kesitlere Avidin-Biyotin kompleks sistemiyle panHPV, HPV-16, HPV-18, p53 ve 
Ki-67 immünohistokimyasal boyaları uygulandı. Parafin bloklardan hazırlanan kesitlerden DNA izolasyonu 
yapıldı. Sonrasında HPV varlığı HybriBio HPV Genoarray Test ile araştırıldı.
BULGULAR: PZR-array hibridizasyon yöntemi ile olguların 15'inde (% 31,9) poliklonal HPV pozitifliği 
saptanmıştır. İki olguda literatürden farklı olarak HPV 68 bulunmuştur. HPV (PZR) pozitif bulunan olgularda 
anlamlı düzeyde yüksek Ki-67 boyanması (p=0,01) saptanmıştır. Tümörlerde diferansiyasyon azaldıkça p53 
(p=0,041) ekspresyonunun arttığı görülmüştür. Ki-67 ile panHPV (p=0,004) ve HPV-16 (p=0,002) boyanması 
karşılaştırıldığında, pozitif olgularda Ki-67 ekspresyonunun yüksek olduğu gözlenmiştir.
SONUÇ: Formalin fiske parafine gömülü dokular HPV varlığının gösterilmesinde kullanılabilir. HybriBio HPV 
Genoarray test metodu diğer metodlara göre kullanımı oldukça basittir ve HPV-DNA saptanmasında kıymetli bir 
araç olabilir. Literatür araştırıldığında şimdiye kadar HPV 68 virüsünün larinks SHK'larında saptanmadığı 
görülmüştür. Ki-67 ve p53 ekspresyonları larinks SHK'larında iyi veya kötü prognoz açısından yol gösterici 
olabilir.
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Frequency of Human Papillomavirus in Larynx Squamous Cell Carcinoma, Clinicopathological 
Correlation of p53 and Ki-67 Expressions
SUMMARY
OBJECTIVE: Human Papillomavirus (HPV) infections have been discussed with regard to laryngeal 
carcinogenesis recent years. This study investigated the presence of HPV in larynx squamous cell carcinomas 
(SCC) via immunohistochemical and Polymerase chain reaction (PCR) array hybridization method and the 
relationship between p53, Ki-67 expression with HPV presence and clinicopathologic parameters.
MATERIAL and METHODS: 47 patients who had been operated for larynx SCC were retrospectively included 
in the study. PanHPV, HPV-16, HPV-18, p53 and Ki-67 immunohistochemical stains were applied to cross-
sections obtained from waxed blocks by means of Avidin-Biyotin complex system. DNA was isolated from the 
cross-sections. The presence of HPV was investigated via a HybriBio HPV GenoArray diagnostic kit.
RESULTS: Polyclonal HPV positivity was detected only in 15 (31.9%) cases by means of PCR-array 
hybridization method. Contrary to the literature, HPV-68 was found in two cases. In HPV (PCR)-positive cases, 
Ki-67 staining was found at high grade (p=0.01). The expression of p53 (p=0.041) increases as differentiation 
decreases in tumors. When comparing Ki-67, panHPV (p=0.004) and HPV-16 (p=0.002) staining, the expression 
of Ki-67 is higher than others in positive cases.
CONCLUSION: Formalin-fixed paraffin-embedded tissues can be used to indicate the presence of HPV. The 
use of the HybriBio HPV GenoArray test was much more straightforward than other methods and is useful in 
detecting HPV-DNA. In the literature, no HPV-68 virus was detected in larynx SCCs until recently. The 
expression of Ki-67 and p53 could be central to prognosis in larynx SCCs.
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Laryngeal cancer is the most common form of 
cancer in the head and neck area and comprises 2% of 
1
all cancers in adults . The incidence varies between 
different countries and has shown an increasing trend 
2
in many studies . Ninety percent  of tumor cases are 
squamous cell carcinomas (SCC) and the main 
predisposing factors are smoking and alcohol. Viral 
infections, malnutrition, and local dietary habits are 
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also factors in the etiology of laryngeal cancer . 
Human Papillomavirus (HPV) is a small DNA 
virus of the family Papovaviridae, which generally 
infects squamous cells. More than 100 types of HPV 
4
have been defined . Biomolecular studies reveal that 
specific mechanisms play roles in HPV-based 
carcinogenesis, and it is assumed that there is a 
relationship between HPV infection and cancers of the 
head and neck. Many studies of the frequency of HPV 
in head and neck cancers reported 34.5% as positive 
5
result . However, localization of a certain tumor group 
varies widely, between 7% and 59%, according to 
6
method or patient characteristics .
In HPV detection and typing, there is increasing 
interest in the use of nucleic acid amplification tests 
for formalin-fixed paraffin-embedded tissues. The 
detection of viral nucleic acids in formalin-fixed 
paraffin-embedded tissues can be complicated, as a 
result of excessive fixation and long-term secondary 
viral DNA/RNA degradation. However, such 
specimens are useful for HPV detection when fresh or 
frozen tissue cannot be obtained, and because most 
surgical pathology specimens are formalin-fixed 
7
paraffin-embedded tissues . Today, HPV detection in 
formalin-fixed paraffin-embedded tissues is based on 
immunohistochemistry-primarily replacing protein 
markers and in-situ Hybridization (ISH) for HPV-
DNA. Immunohistochemical methods have high 
sensitivity but low specificity. On the other hand, ISH 
methods are specific but with low sensitivity, and thus 
the findings can be difficult to assess. Compared to 
immunohistochemistry and ISH, the use of nucleic 
acid amplification tests provides increased analytic 
sensitivity and specifity, and thus can supplement 
8
these techniques . 
The key factor in apoptosis integration with cell 
cycle is p-53 protein, which is a tumor-suppressing 
9
gene product . Many studies reported mutant p53 
protein in larynx SCCs. However, it is controversial 
whether this is an indicator of poor prognosis or not. 
Some studies indicate that the index of tumor 
10
suppressor gene protein is related to poor prognosis , 
11,12
whereas others suggest the opposite .
There is a good correlation between amount of 
mitosis in tumor tissue and nuclear immunoreactivity 
12
of Ki-67, which indicates cell proliferation . The 
prognostic importance of cell proliferation is 
controversial in larynx SCCs. The literature includes 
13
articles reporting that high Ki-67 proliferation index  
is a bad prognostic indicator.  On the other hand, some 
11
studies report no relationship to patient survival .
This study investigated the presence of HPV in 
larynx SCCs via immunohistochemical method and 
the HPV GenoArray test, which is a commercial 
polymerase chain reaction (PCR) array hybridization 
method. In addition, this study presents p53 and Ki-67 
expressions, revealing the relationship of these 
indicators to the presence of HPV and to 
clinicopathologic parameters.
MATERIALS AND METHODS
This study retrospectively included 47 cases that 
w e r e  o p e r a t e d  f o r  l a r y n x  S C C  a t  t h e  
Otorhinolaryngology Clinic of Adnan Menderes 
University, Turkey. Paraffin block samples obtained 
from patients were chosen from the archive of the 
Pathology Department, and cross-sections of these 
blocks were tested for immunohistochemistry and 
PCR. Clinical data of patients was recorded.
Immunohistochemical staining
Haematoxylin and Eosin (H&E) stained 
preparates of cases were re-examined. Cross-sections 
were chosen from blocks that were necrosis-free or 
t h o s e  c o n t a i n i n g  m i n i m u m  n e c r o s i s .  
Immunohistochemical stains were applied to new 
cross-sections obtained from blocks, including: 
panHPV [Human Papilloma Virus (HPV) Ab-3 
T h e r m o  M S - 1 8 2 6 - R 7  ( R T U ) ,  T y p e :  
6,11,16,18,31,33,42,51,52,56,58] , HPV-16 [Anti 
Papillomavirus tube 16 (HPV-16) (CamVir-1) 
Biogenex AM362-5M (RTU)], HPV-18 [Human 
Papilloma virus 18 E7 (HPV-18) (Clone 718-15) 
Thermo MA1-23076], p53 [Rabbit Anti-Human p53 
Monoclonal Antibody (Clone SP5) Spiring MS3056 
(RTU)] and Ki-67 [Rabbit Anti-Human Ki-67 
Monoclonal Antibody (Clone SP6)  Spiring MS3066 
(RTU)]. Immunohistochemical staining was via 
Avidin-Biyotin complex system. Pursuant to staining, 
cross sections were examined under an optical 
microscope (Olympus BX51, Tokyo, Japan) at 4×, 
10×, 20× and 40× magnification. Nuclear staining was 
assessed for all immunohistochemical stains. In the 
most intensely stained area, at least 200 cells were 
found. For Ki-67 and p53, staining percentages were 
scored as follows:  less than 5%: 0; 5–10%: +; 
11–20%: ++; and more than 20%: +++. For PanHPV, 
HPV-16 and HPV-18, semi-quantitative scores were 
"0" for no staining, "+" for focal staining and "++" for 
extensive staining.  
HybriBio HPV GenoArray test 
For PCR and genotyping, between 10 and 20 leaf 
cross-sections of 5–10 micron thickness were 
obtained from paraffin blocks. Specimens were tested 
with a HybriBio HPV GenoArray diagnostic kit 
(GenoArray, HybriBio Ltd., Hong Kong). This test kit 
combines PCR and hybridization methods, and can 
qualitatively detect 21 types of HPV. The test offers a 
macro-array format, through which HPV genotype-
specific oligonucleotide probes are immobilized on 
14
plastic membrane . The sensitivity of the method is 
4–89 genome copy/µl, and varies by HPV genotype. It 
is also reported that there is no cross-reactivity 
15
between different HPV types during hybridization . A 
commercial NucleoSpin Tissue mini column 
(Macherey-Nagel, Duren, Germany) isolation kit was 
used for the removal of paraffin from tissue and for 
14
DNA isolation. Following DNA isolation, HPV typing 
was conducted at three stages: increase of DNA via 
PCR, hybridization, and assessment of results. For the 
increase of HPV DNA with PCR, a 23.24 μl PCR mix, 
0.75 μl DNA Taq polymerase and 1 μl isolated DNA 
were added to PCR tubes for each specimen in line 
with the manufacturers' instructions. PCR tubes 
prepared for the 47 specimens were placed in an 
Eppendorf- branded thermal cycler device for the 
amplification stage. The amplification process 
consisted of denaturation at 95 °C for 9 min. with a 
thermal cycler; then a program comprising 40 cycles at 
95 °C for 20 sec., at 55 °C for 30 sec., and at 72 °C for 
30 sec; and a final extension for 5 min. at 72 °C.
For the hybridization process, square-shaped 
hybridization membranes were placed in a HybriMax 
device. A mixture of 0.5 μl heated hybridization buffer 
and 20 μl PCR products was added to each specimen. 
Following processes conducted in accordance with the 
method, wet membranes were left to dry and the place 
of purple dots on membranes were assessed by eye. 
The accuracy of the test was assessed by the presence 
of amplification points in the first well of the 
membrane and the dot in the well below, indicating 
that the hybridization process was completed. A 
negative result was determined via the presence of 
amplification and hybridization dots combined with a 
lack of dots on the membranes in the wells. A positive 
result was indicated by the presence of amplification 
and hybridization dots, combined with the occurrence 
of dot/s according to the localization of 21 HPV types 
(The kit includes high-risk group: HPV-16, 18, 31, 33, 
35, 39, 45, 51, 52, 56, 58, 59, 66, 68; low-risk group: 6, 
11, 42, 43, 44, 53 and CP8304). 
Statistical Analysis
In the test for Ki-67 and p53, staining between 
0% and 10% was considered low grade, and > 10% 
was considered high-grade staining. 
In the examination of PanHPV, HPV-16 and 
HPV-18, focal and extensive staining was considered 
positive; those without staining were considered 
negative.  
Statistical analysis was conducted with SPSS 
(Statistical Package for the Social Sciences, version 
14.0 for Windows). Definitive statistics used number 
and percentages; intergroup comparisons used chi-
square and Fisher's exact test; comparisons between 
dependent groups used the McNemar test. A p-value 
<0.05 was considered to be significant.  
RESULTS
Clinical and pathologic data of cases are 
presented in Table 1. 
In p53 staining via immunohistochemical 
method, low-grade staining was detected in 22 
(46.8%) cases and high-grade staining was detected in 
25 (53.2%) cases. No significant difference was found 
between p53 and smoking (p=0.611), tumor 
localization (p=0.927), neck metastasis (p=0.790), T 
phase (p=0.381), panHPV staining (p=0.053), HPV-
16 staining (p=0.163) and Ki-67 staining (p=0.210). 
Histological grade showed that as differentiation 
decreases, p53 expression increases (p=0.041).
In immunohistochemical Ki-67 staining, low-
grade staining was detected in 19 (40.4%) cases and 
high-grade staining in 28 (59.6%) cases. No 
significant difference was found between Ki-67 and 
smoking (p=0.137), tumor localization (p=0.990), 
neck metastasis (p=1.00), histological grade 
(p=0.439), T phase (p=1.000). When comparing Ki-67 
and panHPV (p=0.004), HPV-16 (p=0.002) staining, 
the expression of Ki-67 was higher in positive cases 
(Figure 1).
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Gender                      1 Female (2.1%) 
                                 46 Male (97.9%) 
Smoking                  43 smokers (91.5%) 
                                    4 non-smokers (8.5%) 
Histological grade        20 good differential (42.6%) 
                                    22 medium differential (46.8%)
                                    5 low differential (10.6%) 
Tumor localization     7 supraglottic (14.9%) 
                                    20 transglottic (42.6%) 
                                 20 glottic (42.6%) 
TNM staging           15 T1 (31.9%) 
                               11 T2 (23.4%) 
                                  5 T3 (10.6%) 
16 T4 (34%) 
Lymph node involvement  12 metastasis (25.5%) 
Table 1. Clinical and pathologic data of cases.
F i g u r e  1 .  L o w -  ( A )  a n d  h i g h - g r a d e  ( B )  
immunohistochemical staining with p53; low- (C) and high-
grade (D) immunohistochemical staining with Ki-67.
Çetin ve Ark.
In panHPV staining via immunohistochemical 
method, negative staining was detected in 25 (53.2%) 
cases and positive staining in 22 (46.8%) cases. In 
HPV-16 staining, negative staining was detected in 27 
(57.4%) cases and positive staining in 20 (42.6%) 
cases. None of the patients showed positive HPV-18 
staining via immunohistochemical method. In 
panHPV and HPV-16 staining, no significant 
relationship was detected between smoking (p=0.894, 
p=0.458), tumor localization (p=0.620, p=0.587), 
neck metastasis (p=0.797, p=0.517), histological 
grade (p=0.666, p=0.761) and T phase (p=0.491, 
p=0.528). A significant difference was detected 
between panHPV and HPV-16 staining; all cases 
stained with HPV-16 were also stained with panHPV 
(Figure 2).
 Polyclonal HPV positivity was detected in 15 
(31.9%) cases via PCR-array hybridization method. 
HPV-16 was detected in 5 (10.6%) cases, HPV-31 in 1 
(2.1%), HPV-52 in 1 (2.1%) case, HPV-53 in 5 
(10.6%) cases, HPV16 and HPV-5 in 1 (2.1%) case, 
HPV-16 AND HPV-68 in 2 (4.3%) cases (Figure 3). 
No significant difference was found between HPV 
PCR positivity and smoking (p=1.000), tumor 
localization (p=0.318), neck metastasis (p=0.725), 
histological grade (p=0.453), T phase (p=0.414). 
Contrary to the literature, HPV-68 was found in two 
cases (Table 2).
There was no significant difference between 
immunohistochemical panHPV results and HPV 
(PCR) methods (p=0.143). When comparing HPV16 
(PCR) results with immunohistochemical HPV-16 
positivity, a significant difference (p=0.000) was 
found and immunohistochemical positivity was 
observed in cases with HPV-16. HPV-18 was not 
detected with these two methods. In HPV (PCR)-
positive cases, no significant relationship was detected 
16
Figure 2. Immunohistochemical staining with panHPV: 
focal (A) and extensive (B); immunohistochemical staining 
with HPV-16: focal (C) and extensive (D). 
panHPV (immunohistochemistry)   22 positive (46.8%) 
                                                         25 negative (53.2) 
HPV-16 (immunohistochemistry)       20 positive (42.6%) 
                                                       27 negative (57.4%) 
HPV (PCR)                                 15 polyclonal HPV positivity (31.9%) 
                                                            32 negative (68.1%)                                                  
HPV (PCR) Distribution                    5 HPV-16 (10.6%) 
                                                              1 HPV-31 (2.1%) 
                                                              1 HPV-52 (2.1%) 
                                                              5 HPV-53 (10.6%) 
                                                          1 HPV-16 and HPV-52 (2.1%) 
                                                              2 HPV-16 and HP-68 (4.3%) 
Table 2. Rate of HPV in cases.
Figure 3. HybriBio HPV GenoArray test kit, positive (A) 
and negative (B) controls. Hybridization membrane HPV 
type 16 (C), type 52 (D), type 53 (E) and type 68 (F) samples. 
Larinks Primer Skuamöz Hücreli Karsinomlarında Human Papilloma Virüs Sıklığı, p53 Ve Ki-67 Ekspresyonlarının Klinikopatolojik 
Korelasyonu 
with p53 (p=0.989); on the other hand, a statistically 
significant relationship was detected with Ki-67 
(p=0.01) staining.
DISCUSSION
16
Most laryngeal cancers are SCCs . In the 
literature, it is reported that 60% of larynx cancers are 
glottic, 40% are supraglottic, and only 1% or less are 
17
subglottic-located . In this study, glottic tumor-
localization (42.6%) was most common. 
Smoking and alcohol consumption are the most 
18,19
important etiologic factors in laryngeal cancer . 
Smoking is the most common environmental factor, 
20
both as initiator and progressor . The prevalence of 
smoking is lower among women than men. It is 
assumed that passive smokers bear the same risk, 
19
although this has not yet been demonstrated . Low 
socio-economic status, laryngeal papillomatosis and 
18
family history are other etiologic factors . In this 
study, 91.5% of cases were smokers.
p53 gene is a tumor suppressor gene which is 
weighted 53 KDa and located on a short arm (17p13.1) 
of chromosome 17. It controls DNA replication, cell 
21
proliferation and cell death . Various human tumors 
mutate in the p53 gene. This situation leads to 
increased stability of this protein and increased 
immune staining. However, HPV-related cancers 
generally do not mutate in p53. It is revealed that the 
E6 protein of HPV bonds to p53 and its degradation. 
Cells that express HPV E6 protein cannot accumulate 
significant levels of p53 protein pursuant to DNA 
damage. Therefore, p53 loss of function can be related 
to mutation, similarly to HPV-negative head/neck 
cancers; or can be related to rapid degradation, as in 
22
HPV-related cervical cancers . The p53 mutation is 
9
reported in 39–80% of head and neck SCCs . It is 
reported that excessive p53 expression is related to 
precancerous and proliferative activity in malign 
larynx lesions. In addition, it is reported that some 
groups are diagnosed with p53 protein at relatively 
23
high frequency in precancerous lesions of larynx . 
These findings suggest there are some disconformities 
in precancerous lesions of the larynx to indicate the 
importance of p53. Kazkayası et al. reported no 
significant relationship between p53 expression and 
patient age, tumor location, clinic phase, 
histopathologic grading of tumor, alcohol and clinical 
progress; they found a significant relationship 
between excessive p53 expression and lymph node 
24
metastasis . Jacob et al. reported a relationship 
between HPV infection and increased p53 expression 
25
in larynx SCCs . In this study, no relationship was 
observed between the presence of HPV and p53 
staining; however, a significant difference was 
detected at high-grade  (p=0.041).
Ki-67 is a nuclear non-histone protein located on 
chromosome 10. It consists of two molecules 
weighted 345 kDa and 395 kDa. G1 and G2 of cell 
cycle out of G0 are expressed at M and S phases (26). 
The importance of cell proliferation in larynx SCCs 
for prognosis is controversial, because previous 
studies obtained contradictory results. Açıkalın et al. 
found a significant correlation between high Ki-67 
index and age, T phase, lymph node metastasis, 
increased recurrence and short survival period. In the 
same study, no significant relationship was observed 
between Ki-67 and tumor localization or 
13 27
histopathologic grade . Liu et al.  reported that high 
Ki-67 index correlated with T phase and tumor 
differentiation, and was inversely proportional to 
disease-free survival. In the same study, no significant 
relationship was detected between p53 expression and 
clinicopathologic data, and it was reported that p53 
27
expression had no prognostic value . Lera et al. found 
no relationship between clinicopathologic features 
and the expression of Ki-67 and p53 in larynx SCC 
cases; however, they reported that survival was shorter 
in cases with high Ki-67 index, and that p53 does not 
28
influence survival . In the present study, no significant 
difference was detected between Ki-67 expression and 
clinicopathologic parameters, and no correlation is 
found with p53 expression (p=0.210). 
The relationship between HPV and upper-
airway pathologies has been known for approximately 
29
a century . However, in the last three decades, viral 
oncogenic effects have been better revealed in the 
30
literature . It is found that, among forms of head and 
neck cancer, HPV is particularly related to tonsil and 
31
oropharyngeal cancers . The cause and effect 
relationship between HPV and SCCs suggests the 
presence of virus as a risk indicator. High-risk sub-
types of HPV are basically HPV16, 18, 31, 33, 39, 45, 
52, 58, 68 and 69. These types play a role in cervical 
and other anogenital cancers. HPV-6 and HPV-11 are 
"low-risk" types and are rarely found in malign 
16
lesions . 
Immunohistochemistry is performed using 
commercially available monoclonal rat antibody and 
can be obtained commercially. The test can be used for 
3
HPV detection during histopathologic diagnosis . 
32
Dönmez et al.  detected HPV in 37.5% of cases using 
the immunohistochemical method, and concluded that 
staining was technically difficult. In the present study, 
HPV-16 and HPV-18 antibodies that occur in the high-
risk group and panHPV were detected via the 
immunohistochemical method. The resulting 
positive-staining rates were 53.2% with panHPV and 
57.4% with HPV-16. No specific staining was 
detected with HPV-18. A significant correlation 
(p=0.000) was detected between panHPV and HPV-
16. Immunohistochemistry is a cheaper and easier 
method of determining the presence of HPV; however, 
it should be remembered that erroneous staining 
outcomes may occur due to technical reasons. 
In detection of HPV infections, the prevalent 
approach involves the display of viral nucleic acids 
due to non-advantageous virus isolation, or serologic 
Çetin ve Ark.
17
15
tests . Virological tests consist of ISH, Southern blot 
hybridization, dot-blot hybridization, PCR and real 
time PCR. However, the detection power of ISH is 
low. In addition, PCR and real-time PCR require 
specific expensive equipment such as a thermal cycler, 
and these methods are not yet common in hospital 
33
laboratories . The HybriBio GenoArray test used in 
this study is a commercial kit that has recently 
increased in popularity. At the present time, it is used 
in China and there are studies supporting its value in 
4
high-risk HPV detection . 
The argument in HPV-typing methods results 
from the lack of a confirmed method for HPV 
genotyping in formalin-fixed paraffin-embedded 
tissues. Some methods require special instruments and 
may not be easily applied in molecular pathology and 
34
molecular virology laboratories . Recently, various 
methods have been developed to present HPV types in 
wide panels. To date, these methods were only used in 
studies in the USA, and it is seen that they have 
primary benefits for epidemiological studies of HPV 
8
infection . 
Morshed et al. used the PCR method to 
investigate HPV DNA in paraffin and fresh-frozen 
tissues in 54 larynx SCCs. They found that paraffin 
tissues can be used for HPV DNA detection in 
35
retrospective studies . Gorgoulis et al. detected HPV 
positivity in 20 (13%) of 154 larynx SCC cases. They 
detected HPV-6 (1.1%) in 1 case, HPV-16 (16.2%) in 
12 cases, HPV-18 (2.2%) in 2 cases and HPV-33 
36
(1.1%) in 1 case . In the present study, HPV DNA 
isolation of paraffin tissues was made and typing was 
conducted with the genoarray hybridization method. 
Using the PCR method, polyclonal HPV positivity 
was detected only in 15 (31.9%) cases. HPV-16 was 
detected in 5 (10.6%) cases, HPV-31 in 1 (2.1%) case, 
HPV-52 in 1 (2.1%) case, HPV-53 in 5 (10.6%) cases, 
HPV-16 and HPV-52 in 1 (2.1%) case, HPV-16 and 
HPV-68 in 2 (4.3%) cases. Having previously been 
categorized as a medium-risk, HPV-68 has been 
reclassified in the high-risk group in recent years. 
Within the literature, no HPV-68 virus was detected in 
larynx SCCs until recently.
Morshed found a 35.5% prevalence of HPV 
DNA with PCR in 93 laryngeal SCC cases, and 
staining was 27.7% with immunohistochemistry in 
130 cases. In HPV detection, no correlation was found 
between the PCR method and immunohistochemical 
technique. PCR was recommended as the most 
3
sensitive method of HPV detection . In the present 
study, no significant difference was found between 
panHPV staining and PCR results. However, a 
correlation (p=0.000) was detected between HPV-16 
presence detected with PCR and HPV16 positivity 
detected immunohistochemically. Deilson et al. 16 
detected high- risk HPV in 37.3% of 110 larynx SCC 
cases, HPV-16 in 37% of cases, and HPV-18 in 44% of 
cases. In the same study, p53 positivity was found in 
78.2% of cases. It is remarkable that these cases had 
16
high-grade and high Ki-67 index . In the present 
study, high-grade Ki-67 staining was observed in 
cases with panHPV (p=0.004) and HPV-16 (p=0.002) 
positivity. In addition, Ki-67 staining was 
significantly high in cases with HPV (PCR) positivity 
(p=0.01). 
The relationship between HPV and larynx 
cancer has not yet been clarified. Challenges in HPV 
detection and typing may result from temporary 
infections, patched involvement and various methods 
used in studies on the presence of HPV presence and 
from the differing sensitivities of these methods. The 
immunohistochemical detection of HPV is a cheap 
and easy method that can utilize tumor tissues. 
Although it has some weaknesses, such as and 
subjective assessment and potentially erroneous 
results due to technical conditions, it remains a good 
supplementary test for the presence of HPV. For HPV 
detection, the golden standard method is to study HPV 
DNA with PCR on fresh tissue; however, paraffin-
embedded tissues can also be used to indicate the 
presence of HPV. The use of the HybriBio HPV 
GenoArray test has increased in recent years; it is 
much simpler than other methods and can be a 
valuable tool to detect HPV-DNA. 
It is hoped that further HPV studies on larger 
data sets using standard methods will give more 
definitive results. Identifying the presence of HPV 
will shed light the prevention of laryngeal cancers and 
assist HPV vaccination activities.
In the literature, it is not clear how the expression 
of p53 and Ki-67 affect prognosis in larynx carcinoma. 
In the present study, it is assumed that the relationship 
between high-grade and high-grade p53 expression 
can be an indicator of the poor prognosis of p53 
expression. In HPV-positive cases, Ki-67 staining was 
significantly high-grade. The expression of Ki-67 and 
p53 could be central to good or poor prognosis in 
laryngeal SCCs. Further studies are required to better 
understand the importance of these parameters for the 
treatment and follow-up of laryngeal SCCs.
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